General Information of the Compound
Compound ID |
CP0403075
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-(5-cyclohexyl-1,3,4-oxadiazol-2-yl)-4-ethylbenzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H21N3O2
|
||||||||||||||||||
Molecular Weight |
299.374
|
||||||||||||||||||
Canonical SMILES |
CCc1ccc(cc1)C(=O)Nc1nnc(o1)C1CCCCC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H21N3O2/c1-2-12-8-10-13(11-9-12)15(21)18-17-20-19-16(22-17)14-6-4-3-5-7-14/h8-11,14H,2-7H2,1H3,(H,18,20,21)
Show/Hide
|
||||||||||||||||||
InChIKey |
VYWJXDBRSPQELI-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound